Pinterest

Explore Eli Lilly, Technology News, and more!

Nano Pharmaceutical Market 2017 - GSK, Sanofi, Merck, Pfizer, Magforce, Celgene, Eli Lilly, Nanobiotix, Astrazeneca - https://techannouncer.com/nano-pharmaceutical-market-2017-gsk-sanofi-merck-pfizer-magforce-celgene-eli-lilly-nanobiotix-astrazeneca/

A market study based on the “Nano Pharmaceutical Market” across the globe, recently added to the repository of Market Research, is titled ‘Global Nano Pharmaceutical.

He Raised Drug Prices at Eli Lilly. Can He Lower Them for the U.S.?

He Raised Drug Prices at Eli Lilly. Can He Lower Them for the U.S.?

New York Times ePapers - Daily News about Politics, Sports Entertainment, Technology and World News

Eli Lilly and Co. have announced that their experimental Alzheimer’s treatment has failed to slow mental deterioration in its latest study. Consequently, Lilly shares dropped 11.7 percent on Wednesday.

Eli Lilly and Co. have announced that their experimental Alzheimer’s treatment has failed to slow mental deterioration in its latest study. Consequently, Lilly shares dropped percent on Wednesday.

Major Pharma Short Interest Takes a Small Step Back -- KingstoneInvestmentsGroup.com

The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.

Disappointing setback in new mesothelioma clinical trial

Disappointing setback in new mesothelioma clinical trial

EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal: sources - http://www.orthospinenews.com/eu-to-extend-zimmer-biomet-probe-clear-eli-lilly-novartis-deal-sources

EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal: sources

Business Finance News talks about the latest insider selling at Eli Lilly and Co (NYSE:LLY), General Growth Properties Inc (NYSE:GGP) , and Pioneer Natural Resources (NYSE:PXD).

Business Finance News talks about the latest insider selling at Eli Lilly and Co (NYSE:LLY), General Growth Properties Inc (NYSE:GGP) , and Pioneer Natural Resources (NYSE:PXD).

Eli Lilly CEO David Ricks said during a J.P. Morgan Healthcare Conference that 2018 is the “time for action” to ease drug prices. Ricks suggested the pharmaceutical industry could face …

Eli Lilly CEO David Ricks said during a J.P. Morgan Healthcare Conference that 2018 is the “time for action” to ease drug prices. Ricks suggested the pharmaceutical industry could face …

Latest Alzheimer's Flop Raises Doubts About 'Amyloid Hypothesis'

Latest Alzheimer's Flop Raises Doubts About 'Amyloid Hypothesis'

Trump Chooses Alex Azar for Health and Human Services Secretary

Trump Chooses Alex Azar for Health and Human Services Secretary

Former Eli Lilly Executive Is Trump’s Choice for Health Secretary

Eli Lilly is due to announce results of its latest trial into Solanezumab at   the Alzheimer

Have scientists found a drug to stop Alzheimer's disease?

Eli Lilly is due to announce results of its latest trial into Solanezumab at the Alzheimer

AstraZeneca to partner with Eli Lilly on Alzheimer's drug | Reuters

AstraZeneca gets up to $500 million from Lilly for Alzheimer's drug

AstraZeneca earnings hit by waning cholesterol drug sales

Why Eli Lilly Wont Forget This Alzheimers Failure Anytime Soon

Why Eli Lilly Wont Forget This Alzheimers Failure Anytime Soon

Eli Lilly has revealed that its IgG4 monoclonal antibody Taltz (ixekizumab) has been awarded marketing approval from the European Commission for the treatment of active psoriatic arthritis (PsA) in…

Eli Lilly has revealed that its IgG4 monoclonal antibody Taltz (ixekizumab) has been awarded marketing approval from the European Commission for the treatment of active psoriatic arthritis (PsA) in…

Global Diabetes Injection Pen Market 2017 - Novo Nordisk,  Eli Lilly and Company, Sanofi S.A, Becton Dickson and Company - https://techannouncer.com/global-diabetes-injection-pen-market-2017-novo-nordisk-eli-lilly-and-company-sanofi-s-a-becton-dickson-and-company/

Global Diabetes Injection Pen Market 2017 - Novo Nordisk, Eli Lilly and Company, Sanofi S.A, Becton Dickson and Company

Summer babies more likely to end up with dementia  - Telegraph

Summer babies more likely to end up with dementia

Has Stanford University found a cure for Alzheimer's disease? A drug which boosts the brain's immune response could prevent or cure Alzheimer's disease. A new study suggests common diabetes drugs could restore the memories of Alzheimer's disease sufferers